Author details

Full Name

Meenakshi Hegde

Affiliation

ORCID

Career Start Year

2012

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36453638	Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.	Blood advances	2023
35325065	Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.	Blood	2022
34196303	Tandem CAR T cells targeting HER2 and IL13RÎ±2 mitigate tumor antigen escape.	J Clin Invest	2021
32205861	CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression.	Leukemia	2021
33633361	Immunogenicity of CAR T cells in cancer therapy.	Nat Rev Clin Oncol	2021
33952672	A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma.	Science Translational Medicine	2021
34045740	Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.	Nat Med	2021
33660372	Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.	Head and Neck	2021
32669548	Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma.	Nature Communications	2020
31355930	Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.	Cancer	2019
31504801	Immunotherapy for pediatric brain tumors: past and present.	Neuro Oncol	2019
31264975	Tandem CAR T cells targeting HER2 and IL13RÎ±2 mitigate tumor antigen escape.	Journal of Clinical Investigation	2019
30787441	Retraction Note: A homing system targets therapeutic T cells to brain cancer.	Nature	2019
29630926	High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.	Biology of Blood and Marrow Transplantation	2018
29016929	Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma.	Neuro Oncol	2018
30185905	A homing system targets therapeutic T cells to brain cancer.	Nature	2018
29183891	TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.	Cancer Res	2018
29550628	Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.	Biology of Blood and Marrow Transplantation	2018
29196075	Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.	Biology of Blood and Marrow Transplantation	2018
28426845	HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.	JAMA Oncology	2017
27427982	Tandem CAR T cells targeting HER2 and IL13RÎ±2 mitigate tumor antigen escape.	J Clin Invest	2016
25082406	Cellular immunotherapy for pediatric solid tumors.	Cytotherapy	2015
25800760	Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.	Journal of Clinical Oncology	2015
26341370	Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.	J Neurooncol	2015
26202733	Polystyrene microspheres enable 10-color compensation for immunophenotyping of primary human leukocytes.	Cytometry. Part A : the journal of the International Society for Analytical Cytology	2015
24641957	Novel approaches and mechanisms of immunotherapy for glioblastoma.		2014
25505736	Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy.	Frontiers in Oncology	2014
24841514	T cells redirected to interleukin-13RÎ±2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13RÎ±1.	Cytotherapy	2014
23839099	TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy.	Mol Ther Nucleic Acids	2013
22306904	Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.	Journal of Immunotherapy	2012